Pulse Biosciences, Inc., announced that the U.S. FDA has granted approval for the Company’s Investigational Device Exemption, allowing Pulse Biosciences to proceed with the initiation of its nsPFA Cardiac Surgery System Study, NANOCLAMP AF,...
Pulse Biosciences, Inc., announced that the U.S. FDA has granted approval for the Company’s Investigational Device Exemption, allowing Pulse Biosciences to proceed with the initiation of its nsPFA Cardiac Surgery System Study, NANOCLAMP AF,...
Pulse Biosciences, Inc.,...